Human milk is especially essential to render healthy nutrition and to develop the immune system in infants. Human milk contains many types of oligosaccharides and 2’Fucosyllactose is one of them. The 2’Fucosyllactose is a trisaccharide which is a type of oligosaccharide consisting of galactose, glucose and fucose. It is the most important amongst all the oligosaccharides and is absolutely essential in getting healthy nutrition in the infants’ body. Moreover, 2’Fucosyllactose increases the overall anti-infecting capacity in infants. The 2’Fucosyllactose can be consumed mainly by all age groups, but the consumption percentage differs as per the age. The 2’Fucosyllactose is very essential in lowering the risk from infections like viral, bacterial, and other infections. The existing and entering manufacturers of 2’Fucosyllactose have immense opportunities in the market. There is a significant rise in the 2’Ficusyllactose market at the global level which has led to increased competition in the market. Manufacturers are penetrating into the market with new innovations, solutions and fewer prices than the competitors. The global 2’Fucosyllactose market is experiencing noteworthy growth in the Asian, North American, and European markets. Some of the world’s leading players in the 2’Fucosyllactose market are ProZyme Inc., Nestle S.A., DowDuPont Inc., and Jennewein Biotechnologie GmbH.
Awareness Regarding Health Benefits of 2’Fucosyllactose Is Driving the Market
The major factor that is driving the global 2’Fucosyllactose market is that there is a heightened awareness regarding the health benefits of the 2’Fucosyllactose amongst consumers. There is also a significant rise in the overall applications of the 2’Fucosyllactose which is driving the overall market at a rapid pace. Consumers from youngsters to ageing population are shifting towards a healthy lifestyle and healthy diet on a daily basis which is again one of the important factors that are supporting the growth of the 2’Fucosyllactose market across the globe. The inclination of consumers towards including food supplements in their daily diet is largely driving the global 2’Fucosyllactose market. The consumption of 2’Fucosyllactose give many benefits such as an improved immune system in infants, reduced possibility of infections, and provide healthy nutrition which is rendering the overall growth of the market.
Global 2’Fuosyllactose: Market Segmentation
On the basis of the form, the 2’Fucosyllactose market is segmented as:
On the basis of nature, the 2’Fucosyllactose market is segmented as:
On the basis of the end use, the 2’Fucosyllactose market is segmented as:
- Food & beverages
- Infant formulas
- Food supplements
On the basis of the distribution channel, the 2’Fucosyllactose market is segmented as:
- Specialty stores
- Drug stores
- Online stores
Global 2’Fucosyllactose Market: Key Players
Some of the large players in the global 2’Fucosyllactose market are Perrigo Nutritionals, ProZyme Inc., GNUbiotics Sciences, Jennewein Biotechnologie GmbH, Abbott Laboratories, Mead Johnson & Company LLC, Nestle S.A., FreislandCampina Ingredients, Glycosyn LLC, ZuChem Inc., The Honest Co., Medolac Laboratories, Elicityl SA, Glycom A/S, Inbiose NV, Dextra Group, The Hain Celestial Group Inc., DowDuPont Inc., Carbosynth Ltd., and Metagenics Inc. Amongst all ProZyme Inc., DowDuPont Inc., Nestle S.A., and Jennewein Biotechnologie GmbH are the world’s leading manufacturers of human milk oligosaccharides. Recently, Jennewein Biotechnologie GmbH has expanded its business in the Chinese market. In May 2018, FreislandCampina Ingredients was officially certified by EU to use 2’Fucosyllactose in their infant formula products in both European and the US markets.
Opportunities for Market Participants
The global 2’Fucosyllactose market has significant opportunities across the globe. The rise in the innovation to develop cost-effective food processing techniques in the overall human milk oligosaccharides segment is largely providing opportunities to the 2’Fucosyllactose market players over the globe. There is a significant room for the manufacturers in the innovation and advancements of technology in the 2’Fucosyllactose market. The main restraint in the global 2’Fucosyllactose market is the high cost of the production facility. Governments are also taking steps to carry out research on human milk oligosaccharides and mainly on 2’Fucosyllactose.
The 2’Fucosyllactose market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the 2’Fucosyllactose market report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the 2’Fucosyllactose market, including but not limited to: form, nature, end use, and distribution channel.
The study is a source of reliable data on:
- 2’Fucosyllactose market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The 2’Fucosyllactose market report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The 2’Fucosyllactose market report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent 2’Fucosyllactose market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the 2’Fucosyllactose market report projects the attractiveness of each major segment over the forecast period.
Highlights of the 2’Fucosyllactose market report:
- A complete backdrop analysis, which includes an assessment of the parent 2’Fucosyllactose market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the 2’Fucosyllactose market
- Recommendations to companies for strengthening their foothold in the 2’Fucosyllactose market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.